Discovery Labs to Present at the Lazard Capital Markets Healthcare Conference
November 10, 2011 15:15 ET
|
Discovery Laboratories, Inc.
WARRINGTON, Pa., Nov. 10, 2011 (GLOBE NEWSWIRE) -- Discovery Laboratories, Inc. (Nasdaq:DSCO), a specialty biotechnology company dedicated to improving the standard of respiratory critical care...
Discovery Labs' KL4 Surfactant Granted Orphan Drug Designation in Europe for the Treatment of Cystic Fibrosis
November 03, 2011 07:45 ET
|
Discovery Laboratories, Inc.
WARRINGTON, Penn., Nov. 3, 2011 (GLOBE NEWSWIRE) -- Discovery Laboratories, Inc. (Nasdaq:DSCO) today announced that the Committee for Orphan Medicinal Products (COMP) of the European Medicines Agency...
Discovery Labs AFECTAIR(TM) Technology to be Presented at the American Association for Respiratory Care Annual Meeting
November 02, 2011 07:45 ET
|
Discovery Laboratories, Inc.
WARRINGTON, Penn., Nov. 2, 2011 (GLOBE NEWSWIRE) -- Discovery Laboratories, Inc. (Nasdaq:DSCO) will be presenting, for the first time, newdata supporting AFECTAIR™ at the American Association...
Discovery Labs to Report Third Quarter 2011 Results and Hold Conference Call on Thursday, November 10, 2011
October 28, 2011 07:45 ET
|
Discovery Laboratories, Inc.
WARRINGTON, Penn., Oct. 28, 2011 (GLOBE NEWSWIRE) -- Discovery Laboratories, Inc. (Nasdaq:DSCO) will report third quarter 2011 results on Thursday, November 10, 2011 before the open of the U.S....
Discovery Labs Aerosolized KL4 Surfactant Program Data Presented at the European Society for Paediatric Research Annual Meeting
October 19, 2011 07:15 ET
|
Discovery Laboratories, Inc.
WARRINGTON, Pa., Oct. 19, 2011 (GLOBE NEWSWIRE) -- Discovery Laboratories, Inc. (Nasdaq:DSCO), announced that data from two scientific studies regarding the Company's aerosolized KL4 surfactant...
Discovery Labs Proprietary Aerosol Drug Delivery Technology Showcased at the 2011 AdvaMed Annual Meeting
September 29, 2011 07:15 ET
|
Discovery Laboratories, Inc.
WARRINGTON, Penn., Sept. 29, 2011 (GLOBE NEWSWIRE) -- Discovery Laboratories, Inc. (Nasdaq:DSCO) today announced that its proprietary capillary aerosolization technology was selected for presentation...
Discovery Labs Reports Second Quarter Financial Results and Provides an Update on Lead Pipeline Programs
August 03, 2011 07:00 ET
|
Discovery Laboratories, Inc.
WARRINGTON, Pa., Aug. 3, 2011 (GLOBE NEWSWIRE) -- Discovery Laboratories, Inc. (Nasdaq:DSCO), a specialty biotechnology company dedicated to improving the standard of respiratory critical care through...
Discovery Labs Aerosolization Program Yields Potential New Product Offering: AFECTAIR(TM)
July 29, 2011 07:00 ET
|
Discovery Laboratories, Inc.
WARRINGTON, Pa., July 29, 2011 (GLOBE NEWSWIRE) -- Discovery Laboratories, Inc. (Nasdaq:DSCO), a specialty biotechnology company dedicated to improving the standard of respiratory critical care...
Discovery Labs to Report Second Quarter 2011 Results and Hold Conference Call on Wednesday, August 3, 2011
July 22, 2011 07:15 ET
|
Discovery Laboratories, Inc.
WARRINGTON, Pa., July 22, 2011 (GLOBE NEWSWIRE) -- Discovery Laboratories, Inc. (Nasdaq:DSCO) will report second quarter 2011 results on Wednesday, August 3, 2011 before the open of the U.S. financial...
Discovery Labs Announces Date of 2011 Annual Stockholder Meeting
July 22, 2011 07:00 ET
|
Discovery Laboratories, Inc.
WARRINGTON, Pa., July 22, 2011 (GLOBE NEWSWIRE) -- Discovery Laboratories, Inc. (Nasdaq:DSCO) today announced that its Annual Meeting of Stockholders will be held on Monday, October 3, 2011. The...